At home in Australia, Mark Renton started playing football as soon as he could.…
From a boyhood spent on Australian football fields to the frontier of cardiovascular research, Mark Renton's path illustrates how curiosity can quietly redirect a life toward larger questions. Armed with an American Heart Association postdoctoral fellowship, Renton is now investigating pannexin-1 — a protein that may hold the key to understanding why obesity so reliably damages the heart's blood vessels. The work sits at a threshold where molecular biology meets public health urgency, asking whether disease can be intercepted before it ever announces itself.
- Obesity's toll on the heart remains poorly understood at the cellular level, leaving millions without targeted prevention options.
- Pannexin-1 channels, which help blood vessels expand and contract, appear to malfunction under the metabolic pressures of obesity — potentially triggering dangerous vessel spasms and starving the heart of blood.
- The Johnstone lab's discovery that removing pannexin-1 recreates the very vascular dysfunction seen in obese patients sharpens the case that this protein is a central culprit, not a bystander.
- Renton's AHA fellowship now funds a focused investigation into the precise mechanisms, with the goal of identifying intervention points before cardiovascular symptoms emerge.
- If the research holds, it could open a new class of therapies targeting the obesity-heart disease link — and the implications may extend well beyond the coronary vessels to other organs.
Mark Renton grew up playing football in Australia, imagining a future built around athletic performance and exercise science. But somewhere in his undergraduate years, the deeper machinery of the human body pulled his attention inward — away from the training field and toward the laboratory.
Now a postdoctoral researcher, Renton has received an American Heart Association fellowship to pursue a question with sweeping implications: how does obesity damage the coronary blood vessels, and is there a single molecular actor at the center of that damage? His focus is pannexin-1, a protein that governs how blood vessels open and close in response to the body's demands.
Work from the Johnstone lab has already offered a striking clue — when pannexin-1 is removed in experimental models, the resulting vascular dysfunction mirrors what is observed in obese patients. The vessels lose their ability to expand properly, raising the risk of spasms and diminished blood flow to the heart. That parallel suggests pannexin-1 isn't merely associated with the problem; it may be driving it.
The fellowship positions Renton to map that mechanism in detail, with an eye toward therapies that could intervene before obesity ever announces itself as heart disease. Researchers note the findings may carry implications beyond the heart, touching other organs that depend on healthy vascular function. The story is still unfolding, but the protein at its center is coming into sharper focus.
A story is developing around American Heart Association fellowship supports study of protein linking obesity and heart disease. At home in Australia, Mark Renton started playing football as soon as he could. He figured it would eventually lead to a career prescribing strength training and exercise regimens to athletes.
At home in Australia, Mark Renton started playing football as soon as he could. He figured it would eventually lead to a career prescribing strength training and exercise regimens to athletes. But as an undergraduate, the sports science cu…
This account is still unfolding. More context will surface as other outlets pick up the thread and add their own reporting.
The Hearth Conversation Another angle on the story
What happened here?
American Heart Association fellowship supports study of protein linking obesity and heart disease.
Give me the shape of it.
At home in Australia, Mark Renton started playing football as soon as he could. He figured it would eventually lead to a career prescribing strength training and exercise regimens to athletes.
What should we watch for?
Follow this story as developments unfold across multiple outlets.